NRX Pharmaceuticals Inc
Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Nov 14, 2024
NRXP$2.38+4.8%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
S-11 nrxp20241112_s1.htm FORM S-1
As filed with the Securities and Exchange Commission on November 14, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.